home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

IBC's Antiangiogenesis: New Frontiers in Therapeutic Development

 
  July 26, 2005  
     
 
-, Hilton Boston Back Bay, Boston, MA
October 20-21, 2005


The Angiogenesis Foundation and IBC Life Sciences will hold its 3rd Annual Antiangiogenesis: New Frontiers in Therapeutic Development symposium on October 20-21, 2005 in Boston, MA. This symposium will feature cutting edge topics - such as lymphangiogenesis, PDGF-B, TGF-beta, tumor endothelial genetic instability, escape from chronic VEGF suppression - and critical concepts in early detection using angiogenic biomarkers, and the role of angiogenesis imaging in drug development. Updates on Phase 3 agents will be presented, as well as data from new agents in preclinical and early clinical programs. Register or learn more at www.IBCLifeSciences.com/3158; or call IBC at +1-508-616-5550 x1004.
 
 
Organized by: IBC Life Sciences
Invited Speakers: -
 
Deadline for Abstracts: -
 
Registration: Online: www.IBCLifeSciences.com/3158
Phone: +1 508-616-5550
E-mail: reg@ibcusa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.